Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-11 08:19 am Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | FMR LLC | 5,094,729 7.562% | -1,907,379 (-27.24%) | View |
| 2024-02-14 6:19 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital LLC | 6,275,210 8.9% | 2,857,142 (+83.59%) | View |
| 2024-02-13 6:43 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | ALKEON CAPITAL MANAGEMENT LLC | 3,604,096 6.6% | 1,204,844 (+50.22%) | View |
| 2024-02-13 09:26 am Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | Prosight Management LP | 1,578,263 2.9% | -702,515 (-30.80%) | View |
| 2024-02-09 09:28 am Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | FMR LLC | 7,002,108 12.835% | 2,985,500 (+74.33%) | View |
| 2024-02-07 5:09 pm Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 2,995,032 4.5% | -100,616 (-3.25%) | View |
| 2024-02-06 4:12 pm Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | MILLENNIUM MANAGEMENT LLC | 0 0% | -2,433,850 (Position Closed) | View |
| 2024-02-01 4:15 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III L.P. | 4,428,385 6.6% | 4,428,385 (New Position) | View |
| 2024-01-30 4:31 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | VIKING GLOBAL INVESTORS LP | 4,000,000 5.9% | 4,000,000 (New Position) | View |
| 2024-01-29 5:25 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 3,095,648 5.7% | 2,296,307 (+287.28%) | View |
| 2024-01-25 1:24 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Frazier Life Sciences Public Fund L.P. | 4,142,855 6.2% | 4,142,855 (New Position) | View |
| 2023-07-07 4:15 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Nextech Crossover I GP S.a r.l. | 4,285,714 7.9% | 4,285,714 (New Position) | View |
| 2023-06-09 8:15 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Prosight Management LP | 2,280,778 5.1% | 2,280,778 (New Position) | View |
| 2023-02-13 10:15 am Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | ALKEON CAPITAL MANAGEMENT LLC | 2,399,252 6.1% | 2,399,252 (New Position) | View |
| 2023-02-10 1:56 pm Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital LLC | 3,418,068 7.6% | -50,876 (-1.47%) | View |
| 2023-02-09 12:01 pm Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | FMR LLC | 4,016,608 10.148% | -1,890,671 (-32.01%) | View |
| 2023-02-06 09:50 am Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | VICTORY CAPITAL MANAGEMENT INC | 3,459 0.01% | -2,297,773 (-99.85%) | View |
| 2023-01-20 4:09 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | MILLENNIUM MANAGEMENT LLC | 2,433,850 5.4% | 2,433,850 (New Position) | View |
| 2022-12-29 4:41 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | PFIZER INC PFE | 5,376,344 12% | 5,376,344 (New Position) | View |
| 2022-12-27 4:36 pm Sale | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 1,787,569 4.5% | -425,002 (-19.21%) | View |